Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Killer Cells, Natural | 18 | 2024 | 2207 | 3.300 |
Why?
|
Head and Neck Neoplasms | 27 | 2024 | 2915 | 3.210 |
Why?
|
Receptors, Aryl Hydrocarbon | 4 | 2021 | 222 | 1.950 |
Why?
|
Carcinoma, Squamous Cell | 21 | 2023 | 4083 | 1.900 |
Why?
|
Mouth Neoplasms | 7 | 2023 | 598 | 1.540 |
Why?
|
Receptors, Nerve Growth Factor | 3 | 2018 | 200 | 1.010 |
Why?
|
Immunity, Innate | 3 | 2021 | 3076 | 0.890 |
Why?
|
Lymphocyte Subsets | 2 | 2021 | 312 | 0.780 |
Why?
|
Tumor Microenvironment | 11 | 2023 | 3939 | 0.710 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2021 | 178 | 0.690 |
Why?
|
Nasopharyngeal Neoplasms | 4 | 2022 | 290 | 0.670 |
Why?
|
Immunotherapy | 8 | 2023 | 4728 | 0.650 |
Why?
|
Neoplasms, Experimental | 4 | 2018 | 1232 | 0.560 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2016 | 48 | 0.550 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2020 | 326 | 0.550 |
Why?
|
Infant, Premature, Diseases | 1 | 2022 | 712 | 0.530 |
Why?
|
Lymphocytes | 2 | 2021 | 2611 | 0.530 |
Why?
|
Thyroid Diseases | 1 | 2019 | 388 | 0.510 |
Why?
|
Neoplastic Stem Cells | 2 | 2014 | 1357 | 0.500 |
Why?
|
Melanoma | 8 | 2024 | 5740 | 0.490 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1143 | 0.470 |
Why?
|
Microvessels | 4 | 2020 | 586 | 0.450 |
Why?
|
Skin Neoplasms | 9 | 2024 | 5891 | 0.450 |
Why?
|
Nerve Tissue Proteins | 3 | 2018 | 4417 | 0.450 |
Why?
|
Neoplasm Invasiveness | 5 | 2018 | 3637 | 0.440 |
Why?
|
Lymphatic System | 1 | 2015 | 253 | 0.440 |
Why?
|
Sentinel Lymph Node Biopsy | 3 | 2024 | 743 | 0.440 |
Why?
|
Proteoglycans | 1 | 2016 | 807 | 0.430 |
Why?
|
Toll-Like Receptor 2 | 1 | 2015 | 348 | 0.420 |
Why?
|
Histones | 1 | 2023 | 2596 | 0.420 |
Why?
|
Cell Line, Tumor | 16 | 2022 | 17149 | 0.410 |
Why?
|
Vasoconstriction | 4 | 2020 | 594 | 0.410 |
Why?
|
Cell Movement | 5 | 2021 | 5223 | 0.400 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2020 | 9425 | 0.390 |
Why?
|
Microcirculation | 2 | 2020 | 1283 | 0.380 |
Why?
|
Cerebral Hemorrhage | 2 | 2022 | 2665 | 0.380 |
Why?
|
Cell Adhesion Molecules | 1 | 2018 | 1615 | 0.380 |
Why?
|
Immunotherapy, Adoptive | 2 | 2021 | 1505 | 0.380 |
Why?
|
Molecular Targeted Therapy | 3 | 2018 | 2834 | 0.380 |
Why?
|
Antigens, CD | 2 | 2021 | 4022 | 0.370 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1890 | 0.350 |
Why?
|
Immune System | 1 | 2015 | 801 | 0.340 |
Why?
|
Anemia, Sickle Cell | 4 | 2020 | 1065 | 0.340 |
Why?
|
Neoplasms | 9 | 2024 | 22389 | 0.320 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2011 | 267 | 0.320 |
Why?
|
Cerebrovascular Circulation | 4 | 2022 | 2737 | 0.300 |
Why?
|
Mice | 24 | 2024 | 82051 | 0.290 |
Why?
|
Antibodies, Monoclonal | 4 | 2015 | 9261 | 0.290 |
Why?
|
Maxillary Artery | 1 | 2007 | 18 | 0.290 |
Why?
|
Antigens, Neoplasm | 2 | 2014 | 2003 | 0.280 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2023 | 4613 | 0.280 |
Why?
|
Animals | 32 | 2024 | 169424 | 0.270 |
Why?
|
Aneurysm, Infected | 1 | 2007 | 82 | 0.270 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2021 | 8636 | 0.270 |
Why?
|
Humans | 82 | 2024 | 768369 | 0.260 |
Why?
|
Lymphocyte Activation | 4 | 2021 | 5490 | 0.260 |
Why?
|
Natural Cytotoxicity Triggering Receptor 1 | 2 | 2024 | 29 | 0.260 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2022 | 2564 | 0.250 |
Why?
|
NF-kappa B | 6 | 2022 | 2491 | 0.250 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3116 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.250 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 986 | 0.240 |
Why?
|
Thyroid Neoplasms | 4 | 2024 | 2360 | 0.240 |
Why?
|
Disease Models, Animal | 3 | 2021 | 18390 | 0.230 |
Why?
|
Aneurysm, False | 1 | 2007 | 264 | 0.230 |
Why?
|
Cell Growth Processes | 2 | 2015 | 383 | 0.230 |
Why?
|
Organoids | 2 | 2021 | 750 | 0.220 |
Why?
|
Cerebrovascular Disorders | 1 | 2011 | 1487 | 0.220 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1104 | 0.220 |
Why?
|
Histone-Lysine N-Methyltransferase | 3 | 2023 | 697 | 0.220 |
Why?
|
Genes, cdc | 1 | 2023 | 114 | 0.220 |
Why?
|
Infant, Premature | 2 | 2024 | 2124 | 0.220 |
Why?
|
Spectrum Analysis | 2 | 2022 | 450 | 0.210 |
Why?
|
Pandemics | 2 | 2020 | 8751 | 0.210 |
Why?
|
Gastrointestinal Agents | 1 | 2008 | 510 | 0.210 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2016 | 3619 | 0.210 |
Why?
|
Sotos Syndrome | 1 | 2022 | 10 | 0.210 |
Why?
|
Cell Differentiation | 4 | 2021 | 11674 | 0.210 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2023 | 757 | 0.210 |
Why?
|
Music Therapy | 1 | 2024 | 111 | 0.200 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2021 | 66 | 0.190 |
Why?
|
Vascular Diseases | 2 | 2020 | 1162 | 0.190 |
Why?
|
alpha-Globins | 1 | 2020 | 20 | 0.190 |
Why?
|
Liver | 1 | 2016 | 7575 | 0.180 |
Why?
|
Mesenchymal Stem Cells | 1 | 2011 | 1671 | 0.180 |
Why?
|
alpha-Thalassemia | 1 | 2020 | 53 | 0.180 |
Why?
|
Primary Dysautonomias | 1 | 2020 | 28 | 0.180 |
Why?
|
Interleukin-15 | 1 | 2021 | 185 | 0.180 |
Why?
|
Fiber Optic Technology | 1 | 2022 | 291 | 0.170 |
Why?
|
Electrons | 1 | 2021 | 266 | 0.170 |
Why?
|
Homeodomain Proteins | 2 | 2013 | 2431 | 0.170 |
Why?
|
Protein Engineering | 1 | 2024 | 549 | 0.170 |
Why?
|
Mice, Inbred BALB C | 5 | 2018 | 6241 | 0.170 |
Why?
|
Hyperemia | 1 | 2020 | 225 | 0.160 |
Why?
|
Interferon Type I | 1 | 2023 | 565 | 0.160 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2021 | 281 | 0.160 |
Why?
|
Chemokines | 1 | 2023 | 963 | 0.160 |
Why?
|
Chemokines, CXC | 1 | 2020 | 420 | 0.160 |
Why?
|
Lymph Nodes | 4 | 2024 | 3472 | 0.150 |
Why?
|
Laryngectomy | 1 | 2020 | 245 | 0.150 |
Why?
|
Cranial Nerves | 1 | 2018 | 98 | 0.150 |
Why?
|
Infant, Newborn | 9 | 2024 | 26394 | 0.150 |
Why?
|
Models, Immunological | 2 | 2018 | 516 | 0.150 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2103 | 0.140 |
Why?
|
Gene Expression Profiling | 5 | 2020 | 9508 | 0.140 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 2 | 2015 | 306 | 0.140 |
Why?
|
Health Priorities | 1 | 2020 | 379 | 0.140 |
Why?
|
Brain | 7 | 2024 | 27439 | 0.140 |
Why?
|
Integrin alpha1 | 1 | 2016 | 13 | 0.140 |
Why?
|
Hypoparathyroidism | 1 | 2018 | 136 | 0.140 |
Why?
|
Arterioles | 1 | 2017 | 252 | 0.140 |
Why?
|
Integrin alpha2 | 1 | 2016 | 39 | 0.140 |
Why?
|
Boronic Acids | 2 | 2015 | 915 | 0.140 |
Why?
|
Vasodilation | 1 | 2020 | 968 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 4362 | 0.130 |
Why?
|
Thyroidectomy | 2 | 2021 | 915 | 0.130 |
Why?
|
Temperature | 2 | 2020 | 2237 | 0.130 |
Why?
|
Luminescence | 1 | 2016 | 108 | 0.130 |
Why?
|
Microscopy | 1 | 2021 | 909 | 0.130 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5342 | 0.130 |
Why?
|
Ubiquitination | 1 | 2021 | 1010 | 0.130 |
Why?
|
Dermatitis, Contact | 1 | 2016 | 133 | 0.130 |
Why?
|
Appointments and Schedules | 1 | 2020 | 443 | 0.130 |
Why?
|
Cytokines | 6 | 2023 | 7440 | 0.130 |
Why?
|
Tracheostomy | 1 | 2020 | 433 | 0.130 |
Why?
|
Carcinoma | 4 | 2016 | 2341 | 0.130 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 22365 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 616 | 0.130 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2016 | 195 | 0.120 |
Why?
|
Beta Particles | 1 | 2015 | 51 | 0.120 |
Why?
|
Nerve Growth Factor | 1 | 2016 | 157 | 0.120 |
Why?
|
Zymosan | 1 | 2015 | 134 | 0.120 |
Why?
|
Phenotype | 4 | 2024 | 16712 | 0.120 |
Why?
|
Ameloblastoma | 1 | 2015 | 42 | 0.120 |
Why?
|
Pyrazines | 2 | 2015 | 1206 | 0.120 |
Why?
|
Brain Diseases | 1 | 2024 | 1553 | 0.120 |
Why?
|
Jaw Neoplasms | 1 | 2015 | 72 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.120 |
Why?
|
Cells, Cultured | 4 | 2018 | 19035 | 0.120 |
Why?
|
Peripheral Nerves | 1 | 2018 | 492 | 0.120 |
Why?
|
STAT1 Transcription Factor | 1 | 2016 | 343 | 0.120 |
Why?
|
Prognosis | 10 | 2024 | 30031 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 562 | 0.120 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2021 | 1322 | 0.120 |
Why?
|
T-Lymphocytes | 3 | 2024 | 10269 | 0.120 |
Why?
|
Guanosine Triphosphate | 1 | 2015 | 315 | 0.110 |
Why?
|
Ulcer | 1 | 2015 | 204 | 0.110 |
Why?
|
RNA, Ribosomal | 1 | 2015 | 228 | 0.110 |
Why?
|
Pain | 3 | 2018 | 5096 | 0.110 |
Why?
|
Luminescent Measurements | 1 | 2015 | 342 | 0.110 |
Why?
|
RNA Interference | 3 | 2017 | 2832 | 0.110 |
Why?
|
Computers, Handheld | 1 | 2015 | 211 | 0.110 |
Why?
|
Female | 29 | 2024 | 396926 | 0.110 |
Why?
|
Gestational Age | 1 | 2022 | 3615 | 0.110 |
Why?
|
Oral Surgical Procedures | 1 | 2015 | 171 | 0.110 |
Why?
|
Artifacts | 1 | 2022 | 1927 | 0.110 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13709 | 0.110 |
Why?
|
Carcinoma, Basal Cell | 1 | 2018 | 564 | 0.100 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2013 | 158 | 0.100 |
Why?
|
Blood Flow Velocity | 2 | 2021 | 1377 | 0.100 |
Why?
|
Lung Neoplasms | 2 | 2017 | 13589 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2022 | 2882 | 0.100 |
Why?
|
Lymphatic Metastasis | 4 | 2023 | 2930 | 0.100 |
Why?
|
Herpesvirus 4, Human | 2 | 2022 | 1081 | 0.100 |
Why?
|
Mice, Inbred NOD | 2 | 2017 | 1840 | 0.100 |
Why?
|
Immunomagnetic Separation | 1 | 2012 | 79 | 0.100 |
Why?
|
Tissue and Organ Procurement | 1 | 2020 | 983 | 0.100 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2477 | 0.100 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2021 | 2048 | 0.100 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1609 | 0.100 |
Why?
|
Pharyngectomy | 1 | 2011 | 45 | 0.100 |
Why?
|
Transcription Factors | 3 | 2021 | 12176 | 0.100 |
Why?
|
Nitric Oxide | 1 | 2020 | 2146 | 0.100 |
Why?
|
Male | 25 | 2024 | 364761 | 0.100 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 873 | 0.100 |
Why?
|
Program Evaluation | 1 | 2020 | 2508 | 0.090 |
Why?
|
Multienzyme Complexes | 1 | 2015 | 666 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 1637 | 0.090 |
Why?
|
Genes, Viral | 1 | 2012 | 653 | 0.090 |
Why?
|
Positron-Emission Tomography | 2 | 2021 | 6657 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 1998 | 0.090 |
Why?
|
Electroencephalography | 2 | 2024 | 6309 | 0.090 |
Why?
|
RNA, Messenger | 3 | 2018 | 12813 | 0.090 |
Why?
|
RNA, Small Interfering | 2 | 2017 | 3436 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2060 | 0.090 |
Why?
|
Australia | 2 | 2024 | 1264 | 0.090 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4931 | 0.080 |
Why?
|
Survival Analysis | 3 | 2017 | 10127 | 0.080 |
Why?
|
Chromatin | 1 | 2021 | 2973 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20763 | 0.080 |
Why?
|
Biomimetics | 1 | 2011 | 172 | 0.080 |
Why?
|
Electronics | 1 | 2011 | 318 | 0.080 |
Why?
|
Receptors, IgG | 1 | 2012 | 564 | 0.080 |
Why?
|
Palliative Care | 2 | 2022 | 3644 | 0.080 |
Why?
|
Patient Readmission | 1 | 2023 | 3308 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 617 | 0.080 |
Why?
|
Antigens, Differentiation | 1 | 2012 | 919 | 0.080 |
Why?
|
Seizures | 1 | 2022 | 2996 | 0.080 |
Why?
|
Surgery, Computer-Assisted | 1 | 2016 | 1005 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2347 | 0.080 |
Why?
|
Aged, 80 and over | 6 | 2024 | 59679 | 0.080 |
Why?
|
Neoplasm Transplantation | 1 | 2012 | 2017 | 0.080 |
Why?
|
Neoplasm Staging | 3 | 2018 | 11249 | 0.080 |
Why?
|
Glycoproteins | 1 | 2016 | 2207 | 0.080 |
Why?
|
Receptors, KIR3DL1 | 1 | 2008 | 26 | 0.080 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2008 | 47 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1489 | 0.070 |
Why?
|
Prostatectomy | 1 | 2016 | 1840 | 0.070 |
Why?
|
Quality of Life | 2 | 2023 | 13497 | 0.070 |
Why?
|
Patient Selection | 1 | 2020 | 4266 | 0.070 |
Why?
|
Cancer Vaccines | 1 | 2015 | 1044 | 0.070 |
Why?
|
Aged | 13 | 2024 | 171514 | 0.070 |
Why?
|
Middle Aged | 15 | 2024 | 223406 | 0.070 |
Why?
|
Retrospective Studies | 11 | 2024 | 81835 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 2022 | 3922 | 0.070 |
Why?
|
DNA Methylation | 2 | 2022 | 4425 | 0.070 |
Why?
|
T-Lymphocyte Subsets | 1 | 2015 | 1813 | 0.070 |
Why?
|
Antibodies | 2 | 2012 | 2426 | 0.070 |
Why?
|
Mice, SCID | 1 | 2012 | 2633 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3735 | 0.070 |
Why?
|
Adult | 17 | 2024 | 223528 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2260 | 0.070 |
Why?
|
Phosphorylation | 2 | 2015 | 8331 | 0.070 |
Why?
|
HLA-B Antigens | 1 | 2008 | 319 | 0.070 |
Why?
|
MicroRNAs | 2 | 2020 | 3806 | 0.070 |
Why?
|
Data Collection | 1 | 2015 | 3329 | 0.070 |
Why?
|
Activating Transcription Factor 2 | 1 | 2005 | 44 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1885 | 0.060 |
Why?
|
Receptors, Immunologic | 1 | 2012 | 1411 | 0.060 |
Why?
|
Infant | 3 | 2022 | 36496 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2017 | 3590 | 0.060 |
Why?
|
Mice, Knockout | 1 | 2021 | 14483 | 0.060 |
Why?
|
Homeostasis | 1 | 2016 | 3351 | 0.060 |
Why?
|
Salvage Therapy | 1 | 2011 | 1277 | 0.060 |
Why?
|
Depression | 1 | 2024 | 8235 | 0.060 |
Why?
|
Immune Tolerance | 2 | 2022 | 2324 | 0.060 |
Why?
|
Signal Transduction | 5 | 2022 | 23639 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2012 | 2847 | 0.060 |
Why?
|
Promoter Regions, Genetic | 4 | 2021 | 5803 | 0.060 |
Why?
|
Gene Expression | 3 | 2022 | 7605 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2910 | 0.060 |
Why?
|
Monitoring, Physiologic | 2 | 2022 | 1795 | 0.060 |
Why?
|
Transplantation, Heterologous | 1 | 2012 | 2393 | 0.060 |
Why?
|
Glutaminase | 1 | 2023 | 32 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2016 | 4948 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5808 | 0.050 |
Why?
|
Autonomic Nervous System | 2 | 2019 | 709 | 0.050 |
Why?
|
Mutagenesis, Insertional | 1 | 2005 | 662 | 0.050 |
Why?
|
Respiratory Rate | 1 | 2024 | 180 | 0.050 |
Why?
|
Genes, Developmental | 1 | 2022 | 38 | 0.050 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2002 | 56 | 0.050 |
Why?
|
Survival Rate | 4 | 2019 | 12875 | 0.050 |
Why?
|
Transgenes | 1 | 2005 | 1015 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2023 | 288 | 0.050 |
Why?
|
Cross Reactions | 1 | 2024 | 825 | 0.050 |
Why?
|
Flow Cytometry | 2 | 2012 | 5893 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2005 | 753 | 0.050 |
Why?
|
Endoscopy | 1 | 2011 | 1857 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8559 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4582 | 0.050 |
Why?
|
Music | 1 | 2024 | 247 | 0.050 |
Why?
|
Antibodies, Bispecific | 1 | 2024 | 204 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 4 | 2024 | 36840 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2002 | 321 | 0.040 |
Why?
|
Radiation Tolerance | 1 | 2023 | 478 | 0.040 |
Why?
|
Cohort Studies | 5 | 2022 | 41782 | 0.040 |
Why?
|
Hemorheology | 1 | 2020 | 144 | 0.040 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2024 | 555 | 0.040 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2020 | 239 | 0.040 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 380 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 11928 | 0.040 |
Why?
|
Blood Pressure | 3 | 2021 | 8537 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2002 | 674 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2021 | 4294 | 0.040 |
Why?
|
Lymphokines | 1 | 2002 | 927 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2002 | 705 | 0.040 |
Why?
|
Brachial Artery | 1 | 2020 | 374 | 0.040 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2005 | 1355 | 0.040 |
Why?
|
Hypothermia, Induced | 1 | 2024 | 756 | 0.040 |
Why?
|
Intracranial Pressure | 1 | 2021 | 325 | 0.040 |
Why?
|
Stroke | 1 | 2021 | 9790 | 0.040 |
Why?
|
United States | 3 | 2024 | 73120 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2008 | 9558 | 0.040 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2024 | 752 | 0.040 |
Why?
|
Mice, Nude | 2 | 2015 | 3635 | 0.040 |
Why?
|
Mutation | 6 | 2023 | 30235 | 0.040 |
Why?
|
Motion | 1 | 2022 | 788 | 0.040 |
Why?
|
Hypesthesia | 1 | 2018 | 106 | 0.040 |
Why?
|
Rats | 2 | 2012 | 23839 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2011 | 3407 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6537 | 0.040 |
Why?
|
Immunity | 1 | 2023 | 1002 | 0.040 |
Why?
|
Receptor, trkA | 1 | 2018 | 159 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4247 | 0.040 |
Why?
|
Quantitative Trait Loci | 1 | 2005 | 2126 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6278 | 0.030 |
Why?
|
Heart Function Tests | 1 | 2017 | 318 | 0.030 |
Why?
|
Sickle Cell Trait | 1 | 2017 | 86 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2023 | 2964 | 0.030 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3611 | 0.030 |
Why?
|
Biophysical Phenomena | 1 | 2017 | 321 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 1142 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2022 | 873 | 0.030 |
Why?
|
Anthropometry | 1 | 2020 | 1343 | 0.030 |
Why?
|
Head | 1 | 2022 | 927 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15879 | 0.030 |
Why?
|
Time Factors | 4 | 2015 | 40271 | 0.030 |
Why?
|
Saliva | 1 | 2020 | 854 | 0.030 |
Why?
|
Pol1 Transcription Initiation Complex Proteins | 1 | 2015 | 8 | 0.030 |
Why?
|
Keratin-20 | 1 | 2015 | 31 | 0.030 |
Why?
|
RNA Polymerase I | 1 | 2015 | 23 | 0.030 |
Why?
|
Diet | 1 | 2013 | 8098 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6856 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2017 | 22286 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2021 | 1172 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2018 | 1343 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2021 | 1368 | 0.030 |
Why?
|
beta-Thalassemia | 1 | 2017 | 236 | 0.030 |
Why?
|
Protein Kinase C-delta | 1 | 2015 | 115 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1585 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 551 | 0.030 |
Why?
|
Mandibular Neoplasms | 1 | 2015 | 131 | 0.030 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2015 | 287 | 0.030 |
Why?
|
Adipokines | 1 | 2016 | 309 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21157 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2017 | 1503 | 0.030 |
Why?
|
DNA, Ribosomal | 1 | 2015 | 301 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2023 | 1905 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2007 | 4077 | 0.030 |
Why?
|
Occupational Health | 1 | 2020 | 814 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2016 | 11206 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2015 | 743 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2017 | 1496 | 0.030 |
Why?
|
Immunologic Surveillance | 1 | 2013 | 92 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1629 | 0.030 |
Why?
|
Natural Cytotoxicity Triggering Receptor 3 | 1 | 2012 | 14 | 0.030 |
Why?
|
Cell Death | 1 | 2018 | 1684 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1760 | 0.030 |
Why?
|
Mycophenolic Acid | 1 | 2015 | 350 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2002 | 2884 | 0.030 |
Why?
|
Adolescent | 5 | 2020 | 89163 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2020 | 65408 | 0.020 |
Why?
|
Receptor Cross-Talk | 1 | 2012 | 118 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2020 | 10490 | 0.020 |
Why?
|
Maxilla | 1 | 2015 | 489 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2399 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 13025 | 0.020 |
Why?
|
RNA | 1 | 2021 | 2728 | 0.020 |
Why?
|
Thymus Gland | 1 | 2016 | 1266 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2016 | 792 | 0.020 |
Why?
|
Genotype | 2 | 2020 | 13045 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2017 | 1308 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4269 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2017 | 1315 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8730 | 0.020 |
Why?
|
Cell Division | 2 | 2012 | 4479 | 0.020 |
Why?
|
Magnetite Nanoparticles | 1 | 2012 | 318 | 0.020 |
Why?
|
Mandible | 1 | 2015 | 759 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11139 | 0.020 |
Why?
|
Young Adult | 4 | 2020 | 60038 | 0.020 |
Why?
|
Comorbidity | 1 | 2024 | 10601 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 635 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4355 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2730 | 0.020 |
Why?
|
ras Proteins | 1 | 2014 | 1058 | 0.020 |
Why?
|
Radiosurgery | 1 | 2018 | 1354 | 0.020 |
Why?
|
Pyrroles | 1 | 2015 | 1127 | 0.020 |
Why?
|
Quinazolines | 1 | 2015 | 1376 | 0.020 |
Why?
|
Risk Factors | 1 | 2015 | 74915 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3708 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3832 | 0.020 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2008 | 317 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2785 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3901 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 24310 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2012 | 1868 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15879 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15459 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5042 | 0.020 |
Why?
|
S100 Proteins | 1 | 2008 | 217 | 0.020 |
Why?
|
Phagocytosis | 1 | 2012 | 1531 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1766 | 0.020 |
Why?
|
Receptors, NK Cell Lectin-Like | 1 | 2005 | 30 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily A | 1 | 2005 | 21 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3230 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2005 | 121 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14766 | 0.020 |
Why?
|
Models, Biological | 2 | 2017 | 9505 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2022 | 7895 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2015 | 2667 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8051 | 0.010 |
Why?
|
Antigens, Ly | 1 | 2005 | 296 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2015 | 5308 | 0.010 |
Why?
|
Computational Biology | 1 | 2016 | 3549 | 0.010 |
Why?
|
Disease Management | 1 | 2015 | 2533 | 0.010 |
Why?
|
Transcription Factor RelA | 1 | 2005 | 254 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2004 | 210 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39429 | 0.010 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2004 | 199 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2019 | 4538 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2004 | 1056 | 0.010 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2005 | 458 | 0.010 |
Why?
|
Transplantation Chimera | 1 | 2005 | 594 | 0.010 |
Why?
|
Stomatitis | 1 | 2005 | 271 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7449 | 0.010 |
Why?
|
Macrophages | 1 | 2017 | 5797 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9376 | 0.010 |
Why?
|
Mouth Mucosa | 1 | 2005 | 437 | 0.010 |
Why?
|
Cyclin D1 | 1 | 2004 | 454 | 0.010 |
Why?
|
Doxycycline | 1 | 2004 | 347 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2005 | 589 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2861 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4534 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2002 | 816 | 0.010 |
Why?
|
Autoantigens | 1 | 2005 | 893 | 0.010 |
Why?
|
Cytoplasm | 1 | 2005 | 1503 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2002 | 750 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 712 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8510 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14725 | 0.010 |
Why?
|
Keratinocytes | 1 | 2004 | 879 | 0.010 |
Why?
|
beta Catenin | 1 | 2004 | 1048 | 0.010 |
Why?
|
Immunoblotting | 1 | 2002 | 1650 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2004 | 1337 | 0.010 |
Why?
|
Ligands | 1 | 2005 | 3279 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15610 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2005 | 2415 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2702 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42620 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2096 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20232 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2005 | 3164 | 0.010 |
Why?
|
Disease Progression | 1 | 2013 | 13643 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2002 | 3594 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3793 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 3813 | 0.010 |
Why?
|
Trans-Activators | 1 | 2004 | 2858 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 6135 | 0.010 |
Why?
|
Cell Survival | 1 | 2004 | 5800 | 0.010 |
Why?
|
Transfection | 1 | 2002 | 5767 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 6979 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2004 | 2643 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 12426 | 0.010 |
Why?
|
Child | 1 | 2020 | 80856 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3734 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2002 | 3520 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 54913 | 0.010 |
Why?
|
Proteins | 1 | 2004 | 6009 | 0.010 |
Why?
|
Apoptosis | 1 | 2005 | 9526 | 0.010 |
Why?
|